Vitiligo Registry for Adults and Children in the UK

Vitiligo is the most common depigmentation disorder affecting around 1% of the population worldwide. Fifty two percent of patients develop vitiligo before the age of 20 and around 80% develop vitiligo before the age of 30 years old.1 Vitiligo often presents in childhood and tends to be a lifelong disease, requiring prolonged courses of phototherapy. Currently no national or international registry for patients with vitiligo exists. Individual dermatologists maintain a database of such patients, however no coordinated efforts have been made to combine these individual registries into a broader national registry. Finally, recently published British Association of Dermatologists (BAD) guideline for the management of vitiligo, recommended the development of a national registry for people with vitiligo undergoing systemic or light therapy to identify outcomes and safety.

NCT Number	NCT06218082
Lead Sponsor	The Royal Wolverhampton Hospitals NHS Trust Collaborators: Incyte Biosciences International Sàrl
Conditions	Dermatologic Disease, Vitiligo
Enrollment	30 participants
Start Date	2026-05-15
Primary Completion	2027-05 (estimated)
Study Completion	2030-02 (estimated)
Updated on ClinicalTrials.gov	2026-04-09